October 2026Dataset Refreshed: Expanded to 15.17M+ Unique Contacts
[email protected]+1 727-617-0017

What is medical device commercialization?

Also called: MedTech Commercialization GTM, MedTech go-to-market, device launch

Medical device commercialization is everything a company does to bring a cleared or approved device to market and drive adoption: market access and reimbursement, clinical evidence, hospital and surgeon adoption, and sales and marketing.

By John Britton, VP of Marketing, MedicalProspects · Updated November 4, 2026 · Targeting & GTM

Why it matters for healthcare sales and marketing

Regulatory clearance is only the start. Devices succeed when surgeons want them, hospitals approve them through value analysis, payers reimburse the procedure, and the commercial team reaches the right accounts in the right order.

How it works

  1. Evidence: clinical and economic data for clinicians, committees and payers.
  2. Access: coding, coverage and reimbursement for the procedure.
  3. Champions: early-adopter surgeons and specialists, often KOLs.
  4. Hospital approval: value analysis, supply chain and contracting, sometimes through a GPO.
  5. Scale: territory planning, sales coverage and marketing to the wider audience.
Five stages of medical device commercialization: evidence, access and reimbursement, champions, hospital approval, scale.
Device launches need evidence, reimbursement, champions and hospital approval before they scale.

Example

Illustrative scenario. A company launching a new spine implant first reaches spine surgeons who have published on the technique, then targets hospitals and surgery centers where those surgeons operate, bringing value analysis evidence and reimbursement information to each.

Common mistakes

  • Marketing before access. Without reimbursement, adoption stalls.
  • Only reaching surgeons. Hospitals must approve the product too.
  • Launching everywhere at once. Sequence accounts by readiness.

Related terms

  • Value Analysis Committee (VAC)A value analysis committee (VAC) is a multidisciplinary hospital or health system team that reviews requests for new products and decides whether to approve them, weighing clinical evidence, safety, total cost and fit with existing contracts.
  • Key Opinion Leader (KOL)A key opinion leader (KOL) is a clinician whose expertise and reputation shape how peers practice, for example through research, publications, guideline committees, teaching and conference talks.
  • Territory PlanningTerritory planning is dividing a market into sales territories so each rep gets a fair share of potential customers and a workload they can cover. In healthcare, potential is usually measured in target providers, facilities and procedure volume by geography.
  • Group Purchasing Organization (GPO)A group purchasing organization (GPO) negotiates contracts with manufacturers and distributors on behalf of its member hospitals and health systems, using their combined buying volume to win better prices and terms. Members then choose whether to buy on those contracts.
  • Physician Preference Items (PPI)Physician preference items (PPI) are medical devices and supplies, often high-cost implants such as orthopedic, spine and cardiac devices, whose choice is driven mainly by the preference of the physician using them.

Put it to work

← Back to the healthcare GTM glossary